High-dose Vorinostat effective at treating relapsed lymphomas

Patients whose aggressive lymphomas have relapsed or failed to respond to the current front-line chemotherapy regimen now have an effective second line of attack against their disease.

http://www.eurekalert.org/pub_releases/2013-02/fhcr-hve020413.php